Tempest Announces Closing of Up To $8.35 Million Registered Direct Offering of Common Stock and Concurrent Private Placement of Warrants Priced At-the-Market Under Nasdaq Rules
$4.25 million upfront with up to an additional $4.1 million of potential…
Euro NCAP announces 2026 protocol changes to tackle modern driving risks
LEUVEN, BELGIUM – Euro NCAP is making major changes to how it…
MSI Announces ‘MSI Lucky Friday’ Sale with Exciting Deals on Gaming & Productivity Laptops
~ MSI's Black Friday offers live from 23rd to 30th November on…
PhoneX Holdings, Inc. Announces Board Change and Adoption of Long-Term Incentive Plan
New York, NY, Nov. 25, 2025 (GLOBE NEWSWIRE) -- PhoneX Holdings, Inc.…
Ascendis Announces Extension of FDA Review Period for TransCon CNP (navepegritide) for Children with Achondroplasia
November 25, 2025 18:15 ET | Source: Ascendis Pharma – Prescription Drug…
ACASPRESSO Announces Black Friday Mega Sale on Coffee and Blending Appliances
Zhuhai, Nov. 24, 2025 (GLOBE NEWSWIRE) -- ACASPRESSO, an emerging brand in…
Menarini Group Announces New Data on ELZONRIS (tagraxofusp-erzs) to be Presented at the 67th American Society of Hematology Annual Meeting and Exposition
Data spans five abstracts including two oral presentations with important findings for…
Pennsylvania Perio & Implants Announces Strengthened Commitment to Evidence-Based Periodontal and Dental Implant Evaluation in Pennsylvania
York, Pennsylvania, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Pennsylvania Perio & Implants…
Junshi Biosciences Announces Primary Endpoints Met in JS001scs Phase 3 Study for the 1ST-line Treatment of NSQ-NSCLC
SHANGHAI, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd…
Ascentage Pharma Announces Publication of Olverembatinib Phase Ib Safety, Efficacy and Novel Mechanism Data in Gastrointestinal Stromal Tumors in Natures Signal Transduction and Targeted Therapy
Largest prospective clinical trial to-date in a rare subtype of GIST ROCKVILLE,…
